FOLH1 and neoplasm: Since PSMA expression is confined to the tumor neovasculature, and several case reports demonstrated high PSMA uptake in vascular tumors [20, 21], we extended our cohort to include benign, intermediate, and malignant vascular tumors of bone and soft tissue (Fig. 5).